Moreover, because intranasal insulin normalizes hypothalamic neuronal activity in response to glucose ingestion, it could be especially favorable for type 2 diabetes patients who demonstrate distorted brain responses to glucose (18,19). The gene discussed is INS; the disease is type 2 diabetes mellitus.